Truist on Viking Therapeutic (VKTX): 'Riding High On A Winning (GLP+GIP) Combination As Commercial Strategy Takes Shape' Mar 4, 2026 02:13PM
Viking Therapeutic (VKTX) PT Lowered to $118 at Raymond James Feb 12, 2026 06:48AM
Laidlaw Reiterates Buy Rating on Viking Therapeutic (VKTX) Feb 12, 2026 02:45AM
Viking Therapeutics (VKTX) Misses Q4 EPS by 48c Feb 11, 2026 04:35PM
Viking Therapeutics (VKTX) call put ratio 2.8 calls to 1 put as share price up 17.2% Jan 14, 2026 03:03PM
View Older Stories

Jan 8, 2026 07:07AM Viking Therapeutics completes enrollment in VK2735 maintenance trial
Dec 5, 2025 05:41AM Viking Therapeutics (VKTX) call put ratio 5.2 calls to 1 put with a focus on December 5 weekly calls
Nov 20, 2025 06:40AM H.C. Wainwright Reiterates Buy Rating on Viking Therapeutic (VKTX)
Nov 12, 2025 06:43AM Viking Therapeutic (VKTX) PT Raised to $107 at Canaccord Genuity
Nov 6, 2025 07:05AM Viking Therapeutics presents VK2735 obesity data at ObesityWeek 2025
Oct 29, 2025 06:33AM Canaccord Genuity Starts Viking Therapeutic (VKTX) at Buy
Oct 23, 2025 03:23PM Viking Therapeutics (VKTX) call put ratio 5.4 calls to 1 put with a focus on January 50 calls as share price up 9%
Oct 23, 2025 08:51AM Viking Therapeutic (VKTX) PT Raised to $105 at Cantor Fitzgerald
Oct 23, 2025 06:43AM H.C. Wainwright Reiterates Buy Rating on Viking Therapeutic (VKTX)
Oct 23, 2025 02:54AM BTIG Reiterates Buy Rating on Viking Therapeutic (VKTX)
Oct 22, 2025 04:09PM Viking Therapeutics (VKTX) Misses Q3 EPS by 11c
Oct 21, 2025 07:05AM Viking Therapeutics begins VK2735 maintenance dosing trial for obesity
Oct 17, 2025 06:01AM Viking Therapeutics (VKTX) call put ratio 7.8 calls to 1 put with a focus on January 45 calls
Sep 30, 2025 06:50AM H.C. Wainwright Reiterates Buy Rating on Viking Therapeutic (VKTX)
Sep 18, 2025 05:50AM Viking Therapeutics (VKTX) call put ratio 5 calls to 1 put with a focus on November 25 and 37.50 calls
Sep 14, 2025 08:00PM Novo Nordisk (NVO) stock: Barclays breaks down key investor questions and debates
Aug 20, 2025 10:49AM Mizuho Reiterates Outperform Rating on Terns Pharmaceuticals (TERN)
Aug 20, 2025 06:06AM Raymond James Reiterates Strong Buy Rating on Viking Therapeutic (VKTX)
Aug 20, 2025 05:44AM Laidlaw Reiterates Buy Rating on Viking Therapeutic (VKTX)
Aug 20, 2025 04:58AM Viking Therapeutics (VKTX) call put ratio 2.8 calls to 1 put with a focus on August 22 weekly calls
Aug 19, 2025 02:10PM Raymond James Reiterates Strong Buy Rating on Viking Therapeutic (VKTX), PT $122
Aug 19, 2025 01:20PM Morgan Stanley Reiterates Overweight Rating on Viking Therapeutic (VKTX)
Aug 19, 2025 01:17PM Jefferies on Viking Therapeutic (VKTX): 'We think the market is overreacting'
Aug 19, 2025 12:34PM Viking Therapeutic (VKTX) PT Lowered to $29 at Citi
Aug 19, 2025 12:13PM H.C. Wainwright Keeps PT at $102 on Viking Therapeutic (VKTX), 'Varying Sentiments Flying Around, But We Are Happy
Aug 19, 2025 12:09PM Stifel on Viking Therapeutic (VKTX) Sell-Off: 'an over-reaction to the successful Ph.2 VENTURE-Oral (13-week) outcome'
Aug 19, 2025 12:06PM William Blair on Viking Therapeutic (VKTX) Sell-Off: 'extreme and unwarranted'
Aug 19, 2025 11:24AM BTIG Reiterates Buy Rating on Viking Therapeutic (VKTX), PT $125
Aug 19, 2025 09:51AM Truist Securities Reiterates Buy Rating on Viking Therapeutic (VKTX)
Aug 19, 2025 08:36AM Novo Nordisk, Eli Lilly rise after Viking obesity trial data
Aug 19, 2025 08:21AM JPMorgan on Viking Therapeutic (VKTX): 'we still think oral vk-2735 offers strong efficacy with a manageable tolerability profile'
Aug 19, 2025 07:50AM Mizuho: Viking (VKTX) Oral Obesity Program is 'Quite Discouraging'
Aug 18, 2025 06:33AM Piper Sandler on Viking Therapeutic (VKTX): 'Strong Odds of Re-Rating of Oral VK2735 Sales'
Aug 18, 2025 05:18AM Oppenheimer Reiterates Outperform Rating on Viking Therapeutic (VKTX)
Aug 8, 2025 05:38AM Viking Therapeutics (VKTX) call put ratio 5.3 calls to 1 put with a focus on November 45 calls
Jul 24, 2025 09:27AM Stifel Reiterates Buy Rating on Viking Therapeutic (VKTX)
Jul 24, 2025 08:47AM Cantor Fitzgerald Reiterates Overweight Rating on Viking Therapeutic (VKTX)
Jul 24, 2025 06:39AM H.C. Wainwright Reiterates Buy Rating on Viking Therapeutic (VKTX)
Jul 23, 2025 04:07PM Viking Therapeutics (VKTX) Misses Q2 EPS by 13c
Jun 26, 2025 06:43AM H.C. Wainwright Reiterates Buy Rating on Viking Therapeutic (VKTX)
Jun 25, 2025 02:13PM BTIG Reiterates Buy Rating on Viking Therapeutic (VKTX)
Jun 25, 2025 12:05PM Leerink Partners Reiterates Outperform Rating on Viking Therapeutic (VKTX)
Jun 25, 2025 10:13AM H.C. Wainwright on Viking Therapeutic (VKTX): 'We expect the Phase 3 program to continue building on this foundation'
Jun 25, 2025 09:45AM Morgan Stanley on Viking (VKTX): 'we view initiation of large Ph3 studies on schedule as an incremental positive'
Apr 29, 2025 06:34AM Cantor Fitzgerald Starts Viking Therapeutic (VKTX) at Overweight
Apr 24, 2025 07:06AM H.C. Wainwright Reiterates Buy Rating on Viking Therapeutic (VKTX)
Apr 23, 2025 04:12PM Viking Therapeutics (VKTX) Misses Q1 EPS by 8c
Apr 22, 2025 04:19PM Viking Therapeutic (VKTX) PT Lowered to $100 at Oppenheimer
Apr 21, 2025 06:52AM H.C. Wainwright Reiterates Buy Rating on Viking Therapeutic (VKTX)
Apr 8, 2025 05:09AM Goldman Sachs Starts Viking Therapeutic (VKTX) at Neutral
View Older Stories